NONOF - Novo Nordisk once-weekly insulin rejected by FDA
2024-07-11 13:19:08 ET
More on Novo Nordisk
- Novo Nordisk: Buy On Dips
- Novo Nordisk Breaks Out To An All-Time High On China Approval Of Wegovy
- Novo Nordisk: Leading The Fight Against Diabetes And Obesity
- Most patients discontinue Novo’s Wegovy, Ozempic within two years: report
- Study finds patients lost more weight on Mounjaro than Ozempic